These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2417213)

  • 41. Interleukin 2-activated human killer cells are derived from phenotypically heterogeneous precursors.
    Damle NK; Doyle LV; Bradley EC
    J Immunol; 1986 Nov; 137(9):2814-22. PubMed ID: 2944965
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Deficiency of natural killer activity, but not of natural killer binding, in patients with lymphoadenopathy syndrome positive for antibodies to HTLV-III.
    Fontana L; Sirianni MC; de Sanctis G; Carbonari M; Ensoli B; Aiuti F
    Immunobiology; 1986 Jul; 171(4-5):425-35. PubMed ID: 3017846
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Melanoma and immunity.
    Rheins LA; Nordlund JJ
    Immunol Ser; 1989; 46():769-87. PubMed ID: 2484957
    [No Abstract]   [Full Text] [Related]  

  • 44. [Regulation of immune system functions].
    Petrov RV
    Arkh Patol; 1983; 45(4):3-11. PubMed ID: 6191742
    [No Abstract]   [Full Text] [Related]  

  • 45. [Cellular base immunologic recognition. I. Relationship and cooperative interaction between subpopulations of T- and B-lymphocytes during the process of primary immunologic recognition].
    Brondz BD
    Usp Sovrem Biol; 1977; 84(5):219-35. PubMed ID: 27026
    [No Abstract]   [Full Text] [Related]  

  • 46. [Cytotoxic activity of the effector cells as a factor in protective immunity in helminthiases (a review of the literature)].
    Leĭkina ES
    Med Parazitol (Mosk); 1983; 52(2):58-65. PubMed ID: 6343821
    [No Abstract]   [Full Text] [Related]  

  • 47. Induction of cytotoxicity in human peripheral blood mononuclear cells by monoclonal antibody OKT3.
    Jung G; Martin DE; Müller-Eberhard HJ
    J Immunol; 1987 Jul; 139(2):639-44. PubMed ID: 3110277
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Membrane markers, target cell specificity, and sensitivity to biological response modifiers distinguish human natural cytotoxic from human natural killer cells.
    Rola-Pleszczynski M; Lieu H; Sullivan AK; Girard M
    J Clin Invest; 1985 Nov; 76(5):1927-31. PubMed ID: 2932473
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Analysis of the cytolytic activity mediated by natural killer cells from acquired immunodeficiency syndrome patients in response to phytohemagglutinin or anti-CD16 monoclonal antibody.
    Sirianni MC; Mezzaroma I; Aiuti F; Moretta A
    Eur J Immunol; 1994 Aug; 24(8):1874-8. PubMed ID: 8056046
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Phenotypic characteristics of human natural killer cells.
    Perussia B; London L; Trinchieri G
    Biomed Pharmacother; 1985; 39(1):13-8. PubMed ID: 3875369
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A clonal analysis of human peripheral blood lymphocytes displaying natural killer-like activity.
    Roberts K; Moore M
    Eur J Immunol; 1985 May; 15(5):448-56. PubMed ID: 3873338
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular interactions in human T cell-mediated cytotoxicity to EBV II. Monoclonal antibody OKT3 inhibits a post-killer-target recognition/adhesion step.
    Tsoukas CD; Carson DA; Fong S; Vaughan JH
    J Immunol; 1982 Oct; 129(4):1421-5. PubMed ID: 6286765
    [No Abstract]   [Full Text] [Related]  

  • 53. Allogeneic lymphocyte cytotoxicity (ALC) in rats: establishment of an in vitro assay, and direct evidence that cells with natural killer (NK) activity are involved in ALC.
    Rolstad B; Fossum S
    Immunology; 1987 Feb; 60(2):151-7. PubMed ID: 2434415
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Natural cytotoxicity in the neonate: high levels of lymphokine activated killer (LAK) activity.
    Montagna D; Maccario R; Ugazio AG; Mingrat G; Burgio GR
    Clin Exp Immunol; 1988 Jan; 71(1):177-81. PubMed ID: 2964956
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Natural killer cells.
    Kimber I
    Med Lab Sci; 1985 Jan; 42(1):60-77. PubMed ID: 2580211
    [No Abstract]   [Full Text] [Related]  

  • 56. Human natural killer cells analyzed by B73.1, a monoclonal antibody blocking Fc receptor functions. I. Characterization of the lymphocyte subset reactive with B73.1.
    Perussia B; Starr S; Abraham S; Fanning V; Trinchieri G
    J Immunol; 1983 May; 130(5):2133-41. PubMed ID: 6833758
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The importance of cytotoxic cellular immunity in the protection from cytomegalovirus infection.
    Quinnan GV; Rook AH
    Birth Defects Orig Artic Ser; 1984; 20(1):245-61. PubMed ID: 6329365
    [No Abstract]   [Full Text] [Related]  

  • 58. [Characterization of a monoclonal antibody against a differentiation antigen of human natural killer cells (NK cells)].
    Kamprad M; Eichler W; Ladusch M; Fiebig H
    Allerg Immunol (Leipz); 1991; 37(3-4):165-73. PubMed ID: 1793088
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Heterogeneity of natural killer cells.
    Ortaldo JR; Herberman RB
    Annu Rev Immunol; 1984; 2():359-94. PubMed ID: 6399848
    [No Abstract]   [Full Text] [Related]  

  • 60. Natural killer cells in relation to disease and treatment.
    Pedersen BK
    Allergy; 1985 Nov; 40(8):547-57. PubMed ID: 3911816
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.